超崩壊剤市場：タイプ、製剤、治療領域別-2025～2030年の世界予測

超崩壊剤市場は、2023年に5億6,793万米ドルと評価され、2024年には6億2,944万米ドルに達すると予測され、CAGR 10.92%で成長し、2030年には11億7,348万米ドルに達すると予測されています。

超崩壊剤は製薬産業における重要な部品であり、主に錠剤やカプセルの製剤化に使用され、生体液との接触により迅速に崩壊するため、薬剤の迅速な放出と吸収を保証します。その必要性は、効率的なドラッグデリバリーシステムに対する需要の高まりから生じており、その用途は様々なタイプの経口固形剤に及んでいます。最終用途の範囲には、主に即時放出錠剤やカプセル剤に効果的な崩壊ソリューションを必要とする製薬メーカーが含まれます。市場は、速効性の治療を必要とする高齢化人口の増加、製薬技術の進歩、効率的な製造プロセスに大きく依存するジェネリック医薬品へのシフトといった要因によって牽引されています。さらに、医薬品製剤の革新は、より優れた製剤の必要性を推進し続けており、性能、生体適合性、費用対効果を改善した新規化合物を開発する機会を企業に提供しています。医療インフラが拡大する新興市場は、成長の大きな可能性を秘めています。しかし、規制要件が厳しく、技術革新や品質管理に高いコストがかかるため、迅速な市場参入や成長の妨げとなる可能性があります。バイオポリマーのような新しい供給源の研究開発は、生産コストを最小限に抑え、安全性の懸念に対処する画期的な進歩をもたらす可能性があります。さらに、個別化医療や患者中心のドラッグデリバリーシステムへの注目は、オーダーメイドの薬剤放出プロファイルなど、特定の患者のニーズに沿った超崩壊剤のイノベーションに拍車をかける可能性があります。同市場の競合情勢は、絶え間ない技術革新と製品の差別化が特徴であるため、研究開発や戦略的提携に重点を置く必要があります。企業は、先進的な製造技術とサステイナブルプラクティスに投資して、優位に立つことが推奨されます。最後に、規制状況を効率的にナビゲートすることで、新しい超崩壊性製剤の市場投入までの時間を短縮し、市場での地位を高めることができます。

市場力学：急速に進化する超崩壊剤市場の主要市場洞察を公開

超崩壊剤市場は、需要と供給のダイナミックな相互作用によって変貌を遂げています。このような市場力学の進化を理解することで、企業は十分な情報に基づいた投資決定、戦略的決定の精緻化、そして新たなビジネス機会の獲得に備えることができます。これらの動向を包括的に把握することで、企業は政治的、地理的、技術的、社会的、経済的な領域にわたる様々なリスクを軽減することができ、また、消費者行動とそれが製造コストや購買動向に与える影響をより明確に理解することができます。

• 市場促進要因
  • 口腔内崩壊錠とカプセルの消費の増加
  • ジェネリック医薬品の採用増加
• 市場抑制要因
  • 製品の安全性と品質に関する懸念
• 市場機会
  • 製薬産業向けの新しい超崩壊剤の開発
  • 天然の超崩壊剤の受け入れ
• 市場課題
  • 超崩壊剤の製造に伴う高コスト

ポーターのファイブフォース：超崩壊剤市場をナビゲートする戦略ツール

ポーターのファイブフォースフレームワークは、超崩壊剤市場の競合情勢を理解するための重要なツールです。ポーターのファイブフォースフレームワークは、企業の競合を評価し、戦略的機会を探るための明確な手法を記載しています。このフレームワークは、企業が市場内の勢力図を評価し、新規事業の収益性を判断するのに役立ちます。これら洞察により、企業は自社の強みを活かし、弱みに対処し、潜在的な課題を回避することができ、より強靭な市場でのポジショニングを確保することができます。

PESTLE分析：超崩壊剤市場における外部からの影響の把握

外部マクロ環境要因は、超崩壊剤市場の業績力学を形成する上で極めて重要な役割を果たします。政治的、経済的、社会的、技術的、法的、環境的要因の分析は、これらの影響をナビゲートするために必要な情報を記載しています。PESTLE要因を調査することで、企業は潜在的なリスクと機会をよりよく理解することができます。この分析により、企業は規制、消費者の嗜好、経済動向の変化を予測し、先を見越した積極的な意思決定を行う準備ができます。

市場シェア分析：超崩壊剤市場における競合情勢の把握

超崩壊剤市場の詳細な市場シェア分析により、ベンダーの業績を包括的に評価することができます。企業は、収益、顧客ベース、成長率などの主要指標を比較することで、競争上のポジショニングを明らかにすることができます。この分析により、市場の集中、セグメント化、統合の動向が明らかになり、ベンダーは競争が激化する中で自社の地位を高める戦略的意思決定を行うために必要な知見を得ることができます。

FPNVポジショニングマトリックス：超崩壊剤市場におけるベンダーのパフォーマンス評価

FPNVポジショニングマトリックスは、超崩壊剤市場においてベンダーを評価するための重要なツールです。このマトリックスにより、ビジネス組織はベンダーのビジネス戦略と製品満足度に基づき評価することで、目標に沿った十分な情報に基づいた意思決定を行うことができます。4つの象限によりベンダーを明確かつ的確にセグメント化し、戦略目標に最適なパートナーやソリューションを特定することができます。

戦略分析と推奨：超崩壊剤市場における成功への道筋を描く

超崩壊剤市場の戦略分析は、世界市場でのプレゼンス強化を目指す企業にとって不可欠です。主要なリソース、能力、業績指標を見直すことで、企業は成長機会を特定し、改善に取り組むことができます。このアプローチにより、競合情勢における課題を克服し、新たなビジネス機会を活かして長期的な成功を収めるための体制を整えることができます。

本レポートでは、主要な注目セグメントを網羅した市場の包括的な分析を提供しています。

1.市場の浸透度：現在の市場環境の詳細なレビュー、主要企業による広範なデータ、市場でのリーチと全体的な影響力を評価します。

2.市場の開拓度：新興市場における成長機会を特定し、既存セグメントにおける拡大可能性を評価し、将来の成長に向けた戦略的ロードマップを記載しています。

3.市場の多様化：最近の製品発売、未開拓の地域、産業の主要な進歩、市場を形成する戦略的投資を分析します。

4.競合の評価と情報：競合情勢を徹底的に分析し、市場シェア、事業戦略、製品ポートフォリオ、認証、規制当局の承認、特許動向、主要企業の技術進歩などを検証します。

5.製品開発とイノベーション：将来の市場成長を促進すると期待される最先端技術、研究開発活動、製品イノベーションをハイライトしています。

また、利害関係者が十分な情報を得た上で意思決定できるよう、重要な質問にも答えています。

1.現在の市場規模と今後の成長予測は？

2.最高の投資機会を提供する製品、地域はどこか？

3.市場を形成する主要技術動向と規制の影響とは？

4.主要ベンダーの市場シェアと競合ポジションは？

5.ベンダーの市場参入・撤退戦略の原動力となる収益源と戦略的機会は何か？

目次

第1章 序文

第2章 調査手法

第3章 エグゼクティブサマリー

第4章 市場概要

第5章 市場洞察

• 市場力学
  • 促進要因
    • 口腔内崩壊錠やカプセル剤の消費増加
    • ジェネリック医薬品の採用増加
  • 抑制要因
    • 製品の安全性と品質に関する懸念
  • 機会
    • 製薬産業向け新超崩壊剤の開発
    • 自然な超崩壊剤の受け入れ
  • 課題
    • 超崩壊剤の製造に伴う高コスト
• 市場セグメンテーション分析
• ポーターのファイブフォース分析
• PESTEL分析
  • 政治
  • 経済
  • 社会
  • 技術
  • 法律
  • 環境

第6章 超崩壊剤市場：タイプ別

• イントロダクション
• 天然超崩壊剤
  • ガム
  • 粘液
  • オオバコ粘液
• 合成超崩壊剤
  • ケイ酸カルシウム
  • クロスポビドン
  • イオン交換樹脂
  • 改質セルロース
    • クロスカルメロースナトリウム
    • 低置換度ヒドロキシプロピルセルロース
  • 変性デンプン

第7章 超崩壊剤市場：製剤別

• イントロダクション
• 口腔内溶解フィルム
• 錠剤とカプセル

第8章 超崩壊剤市場：治療領域別

• イントロダクション
• 心血管疾患
• 消化器疾患
• 血液疾患
• 感染症
• 炎症性疾患
• 神経疾患
• 腫瘍学

第9章 南北アメリカの超崩壊剤市場

• イントロダクション
• アルゼンチン
• ブラジル
• カナダ
• メキシコ
• 米国

第10章 アジア太平洋の超崩壊剤市場

• イントロダクション
• オーストラリア
• 中国
• インド
• インドネシア
• 日本
• マレーシア
• フィリピン
• シンガポール
• 韓国
• 台湾
• タイ
• ベトナム

第11章 欧州・中東・アフリカの超崩壊剤市場

• イントロダクション
• デンマーク
• エジプト
• フィンランド
• フランス
• ドイツ
• イスラエル
• イタリア
• オランダ
• ナイジェリア
• ノルウェー
• ポーランド
• カタール
• ロシア
• サウジアラビア
• 南アフリカ
• スペイン
• スウェーデン
• スイス
• トルコ
• アラブ首長国連邦
• 英国

第12章 競合情勢

• 市場シェア分析、2023年
• FPNVポジショニングマトリックス、2023年
• 競合シナリオ分析
• 戦略分析と提言

企業一覧

• Anshul Life Sciences
• Asahi Kasei Corporation
• Ashland Global Specialty Chemicals Inc.
• Avantor Performance Materials, LLC
• BASF SE
• DFE Pharma GmbH & Co KG
• DowDuPont Inc.
• FMC Corporation
• Gangwal Chemicals Pvt. Ltd.
• Huber Corporation
• JRS PHARMA GmbH+Co. KG
• Nippon Soda Co., Ltd.
• NITIKA PHARMACEUTICAL SPECIALITIES PVT. LTD.
• Roquette Freres S.A.
• Sigachi Industries Pvt Ltd.

LIST OF FIGURES

• FIGURE 1. SUPERDISINTEGRANTS MARKET RESEARCH PROCESS
• FIGURE 2. SUPERDISINTEGRANTS MARKET SIZE, 2023 VS 2030
• FIGURE 3. GLOBAL SUPERDISINTEGRANTS MARKET SIZE, 2018-2030 (USD MILLION)
• FIGURE 4. GLOBAL SUPERDISINTEGRANTS MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 5. GLOBAL SUPERDISINTEGRANTS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 6. GLOBAL SUPERDISINTEGRANTS MARKET SIZE, BY TYPE, 2023 VS 2030 (%)
• FIGURE 7. GLOBAL SUPERDISINTEGRANTS MARKET SIZE, BY TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 8. GLOBAL SUPERDISINTEGRANTS MARKET SIZE, BY FORMULATION, 2023 VS 2030 (%)
• FIGURE 9. GLOBAL SUPERDISINTEGRANTS MARKET SIZE, BY FORMULATION, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 10. GLOBAL SUPERDISINTEGRANTS MARKET SIZE, BY THERAPEUTIC AREA, 2023 VS 2030 (%)
• FIGURE 11. GLOBAL SUPERDISINTEGRANTS MARKET SIZE, BY THERAPEUTIC AREA, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 12. AMERICAS SUPERDISINTEGRANTS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 13. AMERICAS SUPERDISINTEGRANTS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 14. UNITED STATES SUPERDISINTEGRANTS MARKET SIZE, BY STATE, 2023 VS 2030 (%)
• FIGURE 15. UNITED STATES SUPERDISINTEGRANTS MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 16. ASIA-PACIFIC SUPERDISINTEGRANTS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 17. ASIA-PACIFIC SUPERDISINTEGRANTS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 18. EUROPE, MIDDLE EAST & AFRICA SUPERDISINTEGRANTS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 19. EUROPE, MIDDLE EAST & AFRICA SUPERDISINTEGRANTS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 20. SUPERDISINTEGRANTS MARKET SHARE, BY KEY PLAYER, 2023
• FIGURE 21. SUPERDISINTEGRANTS MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

• TABLE 1. SUPERDISINTEGRANTS MARKET SEGMENTATION & COVERAGE
• TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
• TABLE 3. GLOBAL SUPERDISINTEGRANTS MARKET SIZE, 2018-2030 (USD MILLION)
• TABLE 4. GLOBAL SUPERDISINTEGRANTS MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
• TABLE 5. GLOBAL SUPERDISINTEGRANTS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 6. SUPERDISINTEGRANTS MARKET DYNAMICS
• TABLE 7. GLOBAL SUPERDISINTEGRANTS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 8. GLOBAL SUPERDISINTEGRANTS MARKET SIZE, BY NATURAL SUPERDISINTEGRANTS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 9. GLOBAL SUPERDISINTEGRANTS MARKET SIZE, BY GUMS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 10. GLOBAL SUPERDISINTEGRANTS MARKET SIZE, BY MUCILAGE, BY REGION, 2018-2030 (USD MILLION)
• TABLE 11. GLOBAL SUPERDISINTEGRANTS MARKET SIZE, BY PLANTAGO OVATA MUCILAGE, BY REGION, 2018-2030 (USD MILLION)
• TABLE 12. GLOBAL SUPERDISINTEGRANTS MARKET SIZE, BY NATURAL SUPERDISINTEGRANTS, 2018-2030 (USD MILLION)
• TABLE 13. GLOBAL SUPERDISINTEGRANTS MARKET SIZE, BY SYNTHETIC SUPERDISINTEGRANTS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 14. GLOBAL SUPERDISINTEGRANTS MARKET SIZE, BY CALCIUM SILICATES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 15. GLOBAL SUPERDISINTEGRANTS MARKET SIZE, BY CROSPOVIDONE, BY REGION, 2018-2030 (USD MILLION)
• TABLE 16. GLOBAL SUPERDISINTEGRANTS MARKET SIZE, BY ION EXCHANGE RESINS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 17. GLOBAL SUPERDISINTEGRANTS MARKET SIZE, BY MODIFIED CELLULOSE, BY REGION, 2018-2030 (USD MILLION)
• TABLE 18. GLOBAL SUPERDISINTEGRANTS MARKET SIZE, BY CROSCARMELLOSE SODIUM, BY REGION, 2018-2030 (USD MILLION)
• TABLE 19. GLOBAL SUPERDISINTEGRANTS MARKET SIZE, BY LOW-SUBSTITUTED HYDROXYPROPYL CELLULOSE, BY REGION, 2018-2030 (USD MILLION)
• TABLE 20. GLOBAL SUPERDISINTEGRANTS MARKET SIZE, BY MODIFIED CELLULOSE, 2018-2030 (USD MILLION)
• TABLE 21. GLOBAL SUPERDISINTEGRANTS MARKET SIZE, BY MODIFIED STARCH, BY REGION, 2018-2030 (USD MILLION)
• TABLE 22. GLOBAL SUPERDISINTEGRANTS MARKET SIZE, BY SYNTHETIC SUPERDISINTEGRANTS, 2018-2030 (USD MILLION)
• TABLE 23. GLOBAL SUPERDISINTEGRANTS MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
• TABLE 24. GLOBAL SUPERDISINTEGRANTS MARKET SIZE, BY MOUTH-DISSOLVING FILMS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 25. GLOBAL SUPERDISINTEGRANTS MARKET SIZE, BY TABLETS & CAPSULES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 26. GLOBAL SUPERDISINTEGRANTS MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
• TABLE 27. GLOBAL SUPERDISINTEGRANTS MARKET SIZE, BY CARDIOVASCULAR DISEASES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 28. GLOBAL SUPERDISINTEGRANTS MARKET SIZE, BY GASTROINTESTINAL DISEASES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 29. GLOBAL SUPERDISINTEGRANTS MARKET SIZE, BY HEMATOLOGICAL DISEASES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 30. GLOBAL SUPERDISINTEGRANTS MARKET SIZE, BY INFECTIOUS DISEASES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 31. GLOBAL SUPERDISINTEGRANTS MARKET SIZE, BY INFLAMMATORY DISEASES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 32. GLOBAL SUPERDISINTEGRANTS MARKET SIZE, BY NEUROLOGICAL DISEASES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 33. GLOBAL SUPERDISINTEGRANTS MARKET SIZE, BY ONCOLOGY, BY REGION, 2018-2030 (USD MILLION)
• TABLE 34. AMERICAS SUPERDISINTEGRANTS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 35. AMERICAS SUPERDISINTEGRANTS MARKET SIZE, BY NATURAL SUPERDISINTEGRANTS, 2018-2030 (USD MILLION)
• TABLE 36. AMERICAS SUPERDISINTEGRANTS MARKET SIZE, BY SYNTHETIC SUPERDISINTEGRANTS, 2018-2030 (USD MILLION)
• TABLE 37. AMERICAS SUPERDISINTEGRANTS MARKET SIZE, BY MODIFIED CELLULOSE, 2018-2030 (USD MILLION)
• TABLE 38. AMERICAS SUPERDISINTEGRANTS MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
• TABLE 39. AMERICAS SUPERDISINTEGRANTS MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
• TABLE 40. AMERICAS SUPERDISINTEGRANTS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 41. ARGENTINA SUPERDISINTEGRANTS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 42. ARGENTINA SUPERDISINTEGRANTS MARKET SIZE, BY NATURAL SUPERDISINTEGRANTS, 2018-2030 (USD MILLION)
• TABLE 43. ARGENTINA SUPERDISINTEGRANTS MARKET SIZE, BY SYNTHETIC SUPERDISINTEGRANTS, 2018-2030 (USD MILLION)
• TABLE 44. ARGENTINA SUPERDISINTEGRANTS MARKET SIZE, BY MODIFIED CELLULOSE, 2018-2030 (USD MILLION)
• TABLE 45. ARGENTINA SUPERDISINTEGRANTS MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
• TABLE 46. ARGENTINA SUPERDISINTEGRANTS MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
• TABLE 47. BRAZIL SUPERDISINTEGRANTS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 48. BRAZIL SUPERDISINTEGRANTS MARKET SIZE, BY NATURAL SUPERDISINTEGRANTS, 2018-2030 (USD MILLION)
• TABLE 49. BRAZIL SUPERDISINTEGRANTS MARKET SIZE, BY SYNTHETIC SUPERDISINTEGRANTS, 2018-2030 (USD MILLION)
• TABLE 50. BRAZIL SUPERDISINTEGRANTS MARKET SIZE, BY MODIFIED CELLULOSE, 2018-2030 (USD MILLION)
• TABLE 51. BRAZIL SUPERDISINTEGRANTS MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
• TABLE 52. BRAZIL SUPERDISINTEGRANTS MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
• TABLE 53. CANADA SUPERDISINTEGRANTS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 54. CANADA SUPERDISINTEGRANTS MARKET SIZE, BY NATURAL SUPERDISINTEGRANTS, 2018-2030 (USD MILLION)
• TABLE 55. CANADA SUPERDISINTEGRANTS MARKET SIZE, BY SYNTHETIC SUPERDISINTEGRANTS, 2018-2030 (USD MILLION)
• TABLE 56. CANADA SUPERDISINTEGRANTS MARKET SIZE, BY MODIFIED CELLULOSE, 2018-2030 (USD MILLION)
• TABLE 57. CANADA SUPERDISINTEGRANTS MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
• TABLE 58. CANADA SUPERDISINTEGRANTS MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
• TABLE 59. MEXICO SUPERDISINTEGRANTS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 60. MEXICO SUPERDISINTEGRANTS MARKET SIZE, BY NATURAL SUPERDISINTEGRANTS, 2018-2030 (USD MILLION)
• TABLE 61. MEXICO SUPERDISINTEGRANTS MARKET SIZE, BY SYNTHETIC SUPERDISINTEGRANTS, 2018-2030 (USD MILLION)
• TABLE 62. MEXICO SUPERDISINTEGRANTS MARKET SIZE, BY MODIFIED CELLULOSE, 2018-2030 (USD MILLION)
• TABLE 63. MEXICO SUPERDISINTEGRANTS MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
• TABLE 64. MEXICO SUPERDISINTEGRANTS MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
• TABLE 65. UNITED STATES SUPERDISINTEGRANTS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 66. UNITED STATES SUPERDISINTEGRANTS MARKET SIZE, BY NATURAL SUPERDISINTEGRANTS, 2018-2030 (USD MILLION)
• TABLE 67. UNITED STATES SUPERDISINTEGRANTS MARKET SIZE, BY SYNTHETIC SUPERDISINTEGRANTS, 2018-2030 (USD MILLION)
• TABLE 68. UNITED STATES SUPERDISINTEGRANTS MARKET SIZE, BY MODIFIED CELLULOSE, 2018-2030 (USD MILLION)
• TABLE 69. UNITED STATES SUPERDISINTEGRANTS MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
• TABLE 70. UNITED STATES SUPERDISINTEGRANTS MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
• TABLE 71. UNITED STATES SUPERDISINTEGRANTS MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
• TABLE 72. ASIA-PACIFIC SUPERDISINTEGRANTS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 73. ASIA-PACIFIC SUPERDISINTEGRANTS MARKET SIZE, BY NATURAL SUPERDISINTEGRANTS, 2018-2030 (USD MILLION)
• TABLE 74. ASIA-PACIFIC SUPERDISINTEGRANTS MARKET SIZE, BY SYNTHETIC SUPERDISINTEGRANTS, 2018-2030 (USD MILLION)
• TABLE 75. ASIA-PACIFIC SUPERDISINTEGRANTS MARKET SIZE, BY MODIFIED CELLULOSE, 2018-2030 (USD MILLION)
• TABLE 76. ASIA-PACIFIC SUPERDISINTEGRANTS MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
• TABLE 77. ASIA-PACIFIC SUPERDISINTEGRANTS MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
• TABLE 78. ASIA-PACIFIC SUPERDISINTEGRANTS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 79. AUSTRALIA SUPERDISINTEGRANTS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 80. AUSTRALIA SUPERDISINTEGRANTS MARKET SIZE, BY NATURAL SUPERDISINTEGRANTS, 2018-2030 (USD MILLION)
• TABLE 81. AUSTRALIA SUPERDISINTEGRANTS MARKET SIZE, BY SYNTHETIC SUPERDISINTEGRANTS, 2018-2030 (USD MILLION)
• TABLE 82. AUSTRALIA SUPERDISINTEGRANTS MARKET SIZE, BY MODIFIED CELLULOSE, 2018-2030 (USD MILLION)
• TABLE 83. AUSTRALIA SUPERDISINTEGRANTS MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
• TABLE 84. AUSTRALIA SUPERDISINTEGRANTS MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
• TABLE 85. CHINA SUPERDISINTEGRANTS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 86. CHINA SUPERDISINTEGRANTS MARKET SIZE, BY NATURAL SUPERDISINTEGRANTS, 2018-2030 (USD MILLION)
• TABLE 87. CHINA SUPERDISINTEGRANTS MARKET SIZE, BY SYNTHETIC SUPERDISINTEGRANTS, 2018-2030 (USD MILLION)
• TABLE 88. CHINA SUPERDISINTEGRANTS MARKET SIZE, BY MODIFIED CELLULOSE, 2018-2030 (USD MILLION)
• TABLE 89. CHINA SUPERDISINTEGRANTS MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
• TABLE 90. CHINA SUPERDISINTEGRANTS MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
• TABLE 91. INDIA SUPERDISINTEGRANTS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 92. INDIA SUPERDISINTEGRANTS MARKET SIZE, BY NATURAL SUPERDISINTEGRANTS, 2018-2030 (USD MILLION)
• TABLE 93. INDIA SUPERDISINTEGRANTS MARKET SIZE, BY SYNTHETIC SUPERDISINTEGRANTS, 2018-2030 (USD MILLION)
• TABLE 94. INDIA SUPERDISINTEGRANTS MARKET SIZE, BY MODIFIED CELLULOSE, 2018-2030 (USD MILLION)
• TABLE 95. INDIA SUPERDISINTEGRANTS MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
• TABLE 96. INDIA SUPERDISINTEGRANTS MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
• TABLE 97. INDONESIA SUPERDISINTEGRANTS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 98. INDONESIA SUPERDISINTEGRANTS MARKET SIZE, BY NATURAL SUPERDISINTEGRANTS, 2018-2030 (USD MILLION)
• TABLE 99. INDONESIA SUPERDISINTEGRANTS MARKET SIZE, BY SYNTHETIC SUPERDISINTEGRANTS, 2018-2030 (USD MILLION)
• TABLE 100. INDONESIA SUPERDISINTEGRANTS MARKET SIZE, BY MODIFIED CELLULOSE, 2018-2030 (USD MILLION)
• TABLE 101. INDONESIA SUPERDISINTEGRANTS MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
• TABLE 102. INDONESIA SUPERDISINTEGRANTS MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
• TABLE 103. JAPAN SUPERDISINTEGRANTS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 104. JAPAN SUPERDISINTEGRANTS MARKET SIZE, BY NATURAL SUPERDISINTEGRANTS, 2018-2030 (USD MILLION)
• TABLE 105. JAPAN SUPERDISINTEGRANTS MARKET SIZE, BY SYNTHETIC SUPERDISINTEGRANTS, 2018-2030 (USD MILLION)
• TABLE 106. JAPAN SUPERDISINTEGRANTS MARKET SIZE, BY MODIFIED CELLULOSE, 2018-2030 (USD MILLION)
• TABLE 107. JAPAN SUPERDISINTEGRANTS MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
• TABLE 108. JAPAN SUPERDISINTEGRANTS MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
• TABLE 109. MALAYSIA SUPERDISINTEGRANTS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 110. MALAYSIA SUPERDISINTEGRANTS MARKET SIZE, BY NATURAL SUPERDISINTEGRANTS, 2018-2030 (USD MILLION)
• TABLE 111. MALAYSIA SUPERDISINTEGRANTS MARKET SIZE, BY SYNTHETIC SUPERDISINTEGRANTS, 2018-2030 (USD MILLION)
• TABLE 112. MALAYSIA SUPERDISINTEGRANTS MARKET SIZE, BY MODIFIED CELLULOSE, 2018-2030 (USD MILLION)
• TABLE 113. MALAYSIA SUPERDISINTEGRANTS MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
• TABLE 114. MALAYSIA SUPERDISINTEGRANTS MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
• TABLE 115. PHILIPPINES SUPERDISINTEGRANTS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 116. PHILIPPINES SUPERDISINTEGRANTS MARKET SIZE, BY NATURAL SUPERDISINTEGRANTS, 2018-2030 (USD MILLION)
• TABLE 117. PHILIPPINES SUPERDISINTEGRANTS MARKET SIZE, BY SYNTHETIC SUPERDISINTEGRANTS, 2018-2030 (USD MILLION)
• TABLE 118. PHILIPPINES SUPERDISINTEGRANTS MARKET SIZE, BY MODIFIED CELLULOSE, 2018-2030 (USD MILLION)
• TABLE 119. PHILIPPINES SUPERDISINTEGRANTS MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
• TABLE 120. PHILIPPINES SUPERDISINTEGRANTS MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
• TABLE 121. SINGAPORE SUPERDISINTEGRANTS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 122. SINGAPORE SUPERDISINTEGRANTS MARKET SIZE, BY NATURAL SUPERDISINTEGRANTS, 2018-2030 (USD MILLION)
• TABLE 123. SINGAPORE SUPERDISINTEGRANTS MARKET SIZE, BY SYNTHETIC SUPERDISINTEGRANTS, 2018-2030 (USD MILLION)
• TABLE 124. SINGAPORE SUPERDISINTEGRANTS MARKET SIZE, BY MODIFIED CELLULOSE, 2018-2030 (USD MILLION)
• TABLE 125. SINGAPORE SUPERDISINTEGRANTS MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
• TABLE 126. SINGAPORE SUPERDISINTEGRANTS MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
• TABLE 127. SOUTH KOREA SUPERDISINTEGRANTS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 128. SOUTH KOREA SUPERDISINTEGRANTS MARKET SIZE, BY NATURAL SUPERDISINTEGRANTS, 2018-2030 (USD MILLION)
• TABLE 129. SOUTH KOREA SUPERDISINTEGRANTS MARKET SIZE, BY SYNTHETIC SUPERDISINTEGRANTS, 2018-2030 (USD MILLION)
• TABLE 130. SOUTH KOREA SUPERDISINTEGRANTS MARKET SIZE, BY MODIFIED CELLULOSE, 2018-2030 (USD MILLION)
• TABLE 131. SOUTH KOREA SUPERDISINTEGRANTS MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
• TABLE 132. SOUTH KOREA SUPERDISINTEGRANTS MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
• TABLE 133. TAIWAN SUPERDISINTEGRANTS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 134. TAIWAN SUPERDISINTEGRANTS MARKET SIZE, BY NATURAL SUPERDISINTEGRANTS, 2018-2030 (USD MILLION)
• TABLE 135. TAIWAN SUPERDISINTEGRANTS MARKET SIZE, BY SYNTHETIC SUPERDISINTEGRANTS, 2018-2030 (USD MILLION)
• TABLE 136. TAIWAN SUPERDISINTEGRANTS MARKET SIZE, BY MODIFIED CELLULOSE, 2018-2030 (USD MILLION)
• TABLE 137. TAIWAN SUPERDISINTEGRANTS MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
• TABLE 138. TAIWAN SUPERDISINTEGRANTS MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
• TABLE 139. THAILAND SUPERDISINTEGRANTS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 140. THAILAND SUPERDISINTEGRANTS MARKET SIZE, BY NATURAL SUPERDISINTEGRANTS, 2018-2030 (USD MILLION)
• TABLE 141. THAILAND SUPERDISINTEGRANTS MARKET SIZE, BY SYNTHETIC SUPERDISINTEGRANTS, 2018-2030 (USD MILLION)
• TABLE 142. THAILAND SUPERDISINTEGRANTS MARKET SIZE, BY MODIFIED CELLULOSE, 2018-2030 (USD MILLION)
• TABLE 143. THAILAND SUPERDISINTEGRANTS MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
• TABLE 144. THAILAND SUPERDISINTEGRANTS MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
• TABLE 145. VIETNAM SUPERDISINTEGRANTS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 146. VIETNAM SUPERDISINTEGRANTS MARKET SIZE, BY NATURAL SUPERDISINTEGRANTS, 2018-2030 (USD MILLION)
• TABLE 147. VIETNAM SUPERDISINTEGRANTS MARKET SIZE, BY SYNTHETIC SUPERDISINTEGRANTS, 2018-2030 (USD MILLION)
• TABLE 148. VIETNAM SUPERDISINTEGRANTS MARKET SIZE, BY MODIFIED CELLULOSE, 2018-2030 (USD MILLION)
• TABLE 149. VIETNAM SUPERDISINTEGRANTS MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
• TABLE 150. VIETNAM SUPERDISINTEGRANTS MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
• TABLE 151. EUROPE, MIDDLE EAST & AFRICA SUPERDISINTEGRANTS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 152. EUROPE, MIDDLE EAST & AFRICA SUPERDISINTEGRANTS MARKET SIZE, BY NATURAL SUPERDISINTEGRANTS, 2018-2030 (USD MILLION)
• TABLE 153. EUROPE, MIDDLE EAST & AFRICA SUPERDISINTEGRANTS MARKET SIZE, BY SYNTHETIC SUPERDISINTEGRANTS, 2018-2030 (USD MILLION)
• TABLE 154. EUROPE, MIDDLE EAST & AFRICA SUPERDISINTEGRANTS MARKET SIZE, BY MODIFIED CELLULOSE, 2018-2030 (USD MILLION)
• TABLE 155. EUROPE, MIDDLE EAST & AFRICA SUPERDISINTEGRANTS MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
• TABLE 156. EUROPE, MIDDLE EAST & AFRICA SUPERDISINTEGRANTS MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
• TABLE 157. EUROPE, MIDDLE EAST & AFRICA SUPERDISINTEGRANTS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 158. DENMARK SUPERDISINTEGRANTS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 159. DENMARK SUPERDISINTEGRANTS MARKET SIZE, BY NATURAL SUPERDISINTEGRANTS, 2018-2030 (USD MILLION)
• TABLE 160. DENMARK SUPERDISINTEGRANTS MARKET SIZE, BY SYNTHETIC SUPERDISINTEGRANTS, 2018-2030 (USD MILLION)
• TABLE 161. DENMARK SUPERDISINTEGRANTS MARKET SIZE, BY MODIFIED CELLULOSE, 2018-2030 (USD MILLION)
• TABLE 162. DENMARK SUPERDISINTEGRANTS MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
• TABLE 163. DENMARK SUPERDISINTEGRANTS MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
• TABLE 164. EGYPT SUPERDISINTEGRANTS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 165. EGYPT SUPERDISINTEGRANTS MARKET SIZE, BY NATURAL SUPERDISINTEGRANTS, 2018-2030 (USD MILLION)
• TABLE 166. EGYPT SUPERDISINTEGRANTS MARKET SIZE, BY SYNTHETIC SUPERDISINTEGRANTS, 2018-2030 (USD MILLION)
• TABLE 167. EGYPT SUPERDISINTEGRANTS MARKET SIZE, BY MODIFIED CELLULOSE, 2018-2030 (USD MILLION)
• TABLE 168. EGYPT SUPERDISINTEGRANTS MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
• TABLE 169. EGYPT SUPERDISINTEGRANTS MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
• TABLE 170. FINLAND SUPERDISINTEGRANTS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 171. FINLAND SUPERDISINTEGRANTS MARKET SIZE, BY NATURAL SUPERDISINTEGRANTS, 2018-2030 (USD MILLION)
• TABLE 172. FINLAND SUPERDISINTEGRANTS MARKET SIZE, BY SYNTHETIC SUPERDISINTEGRANTS, 2018-2030 (USD MILLION)
• TABLE 173. FINLAND SUPERDISINTEGRANTS MARKET SIZE, BY MODIFIED CELLULOSE, 2018-2030 (USD MILLION)
• TABLE 174. FINLAND SUPERDISINTEGRANTS MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
• TABLE 175. FINLAND SUPERDISINTEGRANTS MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
• TABLE 176. FRANCE SUPERDISINTEGRANTS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 177. FRANCE SUPERDISINTEGRANTS MARKET SIZE, BY NATURAL SUPERDISINTEGRANTS, 2018-2030 (USD MILLION)
• TABLE 178. FRANCE SUPERDISINTEGRANTS MARKET SIZE, BY SYNTHETIC SUPERDISINTEGRANTS, 2018-2030 (USD MILLION)
• TABLE 179. FRANCE SUPERDISINTEGRANTS MARKET SIZE, BY MODIFIED CELLULOSE, 2018-2030 (USD MILLION)
• TABLE 180. FRANCE SUPERDISINTEGRANTS MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
• TABLE 181. FRANCE SUPERDISINTEGRANTS MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
• TABLE 182. GERMANY SUPERDISINTEGRANTS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 183. GERMANY SUPERDISINTEGRANTS MARKET SIZE, BY NATURAL SUPERDISINTEGRANTS, 2018-2030 (USD MILLION)
• TABLE 184. GERMANY SUPERDISINTEGRANTS MARKET SIZE, BY SYNTHETIC SUPERDISINTEGRANTS, 2018-2030 (USD MILLION)
• TABLE 185. GERMANY SUPERDISINTEGRANTS MARKET SIZE, BY MODIFIED CELLULOSE, 2018-2030 (USD MILLION)
• TABLE 186. GERMANY SUPERDISINTEGRANTS MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
• TABLE 187. GERMANY SUPERDISINTEGRANTS MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
• TABLE 188. ISRAEL SUPERDISINTEGRANTS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 189. ISRAEL SUPERDISINTEGRANTS MARKET SIZE, BY NATURAL SUPERDISINTEGRANTS, 2018-2030 (USD MILLION)
• TABLE 190. ISRAEL SUPERDISINTEGRANTS MARKET SIZE, BY SYNTHETIC SUPERDISINTEGRANTS, 2018-2030 (USD MILLION)
• TABLE 191. ISRAEL SUPERDISINTEGRANTS MARKET SIZE, BY MODIFIED CELLULOSE, 2018-2030 (USD MILLION)
• TABLE 192. ISRAEL SUPERDISINTEGRANTS MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
• TABLE 193. ISRAEL SUPERDISINTEGRANTS MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
• TABLE 194. ITALY SUPERDISINTEGRANTS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 195. ITALY SUPERDISINTEGRANTS MARKET SIZE, BY NATURAL SUPERDISINTEGRANTS, 2018-2030 (USD MILLION)
• TABLE 196. ITALY SUPERDISINTEGRANTS MARKET SIZE, BY SYNTHETIC SUPERDISINTEGRANTS, 2018-2030 (USD MILLION)
• TABLE 197. ITALY SUPERDISINTEGRANTS MARKET SIZE, BY MODIFIED CELLULOSE, 2018-2030 (USD MILLION)
• TABLE 198. ITALY SUPERDISINTEGRANTS MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
• TABLE 199. ITALY SUPERDISINTEGRANTS MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
• TABLE 200. NETHERLANDS SUPERDISINTEGRANTS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 201. NETHERLANDS SUPERDISINTEGRANTS MARKET SIZE, BY NATURAL SUPERDISINTEGRANTS, 2018-2030 (USD MILLION)
• TABLE 202. NETHERLANDS SUPERDISINTEGRANTS MARKET SIZE, BY SYNTHETIC SUPERDISINTEGRANTS, 2018-2030 (USD MILLION)
• TABLE 203. NETHERLANDS SUPERDISINTEGRANTS MARKET SIZE, BY MODIFIED CELLULOSE, 2018-2030 (USD MILLION)
• TABLE 204. NETHERLANDS SUPERDISINTEGRANTS MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
• TABLE 205. NETHERLANDS SUPERDISINTEGRANTS MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
• TABLE 206. NIGERIA SUPERDISINTEGRANTS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 207. NIGERIA SUPERDISINTEGRANTS MARKET SIZE, BY NATURAL SUPERDISINTEGRANTS, 2018-2030 (USD MILLION)
• TABLE 208. NIGERIA SUPERDISINTEGRANTS MARKET SIZE, BY SYNTHETIC SUPERDISINTEGRANTS, 2018-2030 (USD MILLION)
• TABLE 209. NIGERIA SUPERDISINTEGRANTS MARKET SIZE, BY MODIFIED CELLULOSE, 2018-2030 (USD MILLION)
• TABLE 210. NIGERIA SUPERDISINTEGRANTS MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
• TABLE 211. NIGERIA SUPERDISINTEGRANTS MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
• TABLE 212. NORWAY SUPERDISINTEGRANTS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 213. NORWAY SUPERDISINTEGRANTS MARKET SIZE, BY NATURAL SUPERDISINTEGRANTS, 2018-2030 (USD MILLION)
• TABLE 214. NORWAY SUPERDISINTEGRANTS MARKET SIZE, BY SYNTHETIC SUPERDISINTEGRANTS, 2018-2030 (USD MILLION)
• TABLE 215. NORWAY SUPERDISINTEGRANTS MARKET SIZE, BY MODIFIED CELLULOSE, 2018-2030 (USD MILLION)
• TABLE 216. NORWAY SUPERDISINTEGRANTS MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
• TABLE 217. NORWAY SUPERDISINTEGRANTS MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
• TABLE 218. POLAND SUPERDISINTEGRANTS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 219. POLAND SUPERDISINTEGRANTS MARKET SIZE, BY NATURAL SUPERDISINTEGRANTS, 2018-2030 (USD MILLION)
• TABLE 220. POLAND SUPERDISINTEGRANTS MARKET SIZE, BY SYNTHETIC SUPERDISINTEGRANTS, 2018-2030 (USD MILLION)
• TABLE 221. POLAND SUPERDISINTEGRANTS MARKET SIZE, BY MODIFIED CELLULOSE, 2018-2030 (USD MILLION)
• TABLE 222. POLAND SUPERDISINTEGRANTS MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
• TABLE 223. POLAND SUPERDISINTEGRANTS MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
• TABLE 224. QATAR SUPERDISINTEGRANTS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 225. QATAR SUPERDISINTEGRANTS MARKET SIZE, BY NATURAL SUPERDISINTEGRANTS, 2018-2030 (USD MILLION)
• TABLE 226. QATAR SUPERDISINTEGRANTS MARKET SIZE, BY SYNTHETIC SUPERDISINTEGRANTS, 2018-2030 (USD MILLION)
• TABLE 227. QATAR SUPERDISINTEGRANTS MARKET SIZE, BY MODIFIED CELLULOSE, 2018-2030 (USD MILLION)
• TABLE 228. QATAR SUPERDISINTEGRANTS MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
• TABLE 229. QATAR SUPERDISINTEGRANTS MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
• TABLE 230. RUSSIA SUPERDISINTEGRANTS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 231. RUSSIA SUPERDISINTEGRANTS MARKET SIZE, BY NATURAL SUPERDISINTEGRANTS, 2018-2030 (USD MILLION)
• TABLE 232. RUSSIA SUPERDISINTEGRANTS MARKET SIZE, BY SYNTHETIC SUPERDISINTEGRANTS, 2018-2030 (USD MILLION)
• TABLE 233. RUSSIA SUPERDISINTEGRANTS MARKET SIZE, BY MODIFIED CELLULOSE, 2018-2030 (USD MILLION)
• TABLE 234. RUSSIA SUPERDISINTEGRANTS MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
• TABLE 235. RUSSIA SUPERDISINTEGRANTS MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
• TABLE 236. SAUDI ARABIA SUPERDISINTEGRANTS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 237. SAUDI ARABIA SUPERDISINTEGRANTS MARKET SIZE, BY NATURAL SUPERDISINTEGRANTS, 2018-2030 (USD MILLION)
• TABLE 238. SAUDI ARABIA SUPERDISINTEGRANTS MARKET SIZE, BY SYNTHETIC SUPERDISINTEGRANTS, 2018-2030 (USD MILLION)
• TABLE 239. SAUDI ARABIA SUPERDISINTEGRANTS MARKET SIZE, BY MODIFIED CELLULOSE, 2018-2030 (USD MILLION)
• TABLE 240. SAUDI ARABIA SUPERDISINTEGRANTS MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
• TABLE 241. SAUDI ARABIA SUPERDISINTEGRANTS MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
• TABLE 242. SOUTH AFRICA SUPERDISINTEGRANTS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 243. SOUTH AFRICA SUPERDISINTEGRANTS MARKET SIZE, BY NATURAL SUPERDISINTEGRANTS, 2018-2030 (USD MILLION)
• TABLE 244. SOUTH AFRICA SUPERDISINTEGRANTS MARKET SIZE, BY SYNTHETIC SUPERDISINTEGRANTS, 2018-2030 (USD MILLION)
• TABLE 245. SOUTH AFRICA SUPERDISINTEGRANTS MARKET SIZE, BY MODIFIED CELLULOSE, 2018-2030 (USD MILLION)
• TABLE 246. SOUTH AFRICA SUPERDISINTEGRANTS MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
• TABLE 247. SOUTH AFRICA SUPERDISINTEGRANTS MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
• TABLE 248. SPAIN SUPERDISINTEGRANTS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 249. SPAIN SUPERDISINTEGRANTS MARKET SIZE, BY NATURAL SUPERDISINTEGRANTS, 2018-2030 (USD MILLION)
• TABLE 250. SPAIN SUPERDISINTEGRANTS MARKET SIZE, BY SYNTHETIC SUPERDISINTEGRANTS, 2018-2030 (USD MILLION)
• TABLE 251. SPAIN SUPERDISINTEGRANTS MARKET SIZE, BY MODIFIED CELLULOSE, 2018-2030 (USD MILLION)
• TABLE 252. SPAIN SUPERDISINTEGRANTS MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
• TABLE 253. SPAIN SUPERDISINTEGRANTS MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
• TABLE 254. SWEDEN SUPERDISINTEGRANTS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 255. SWEDEN SUPERDISINTEGRANTS MARKET SIZE, BY NATURAL SUPERDISINTEGRANTS, 2018-2030 (USD MILLION)
• TABLE 256. SWEDEN SUPERDISINTEGRANTS MARKET SIZE, BY SYNTHETIC SUPERDISINTEGRANTS, 2018-2030 (USD MILLION)
• TABLE 257. SWEDEN SUPERDISINTEGRANTS MARKET SIZE, BY MODIFIED CELLULOSE, 2018-2030 (USD MILLION)
• TABLE 258. SWEDEN SUPERDISINTEGRANTS MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
• TABLE 259. SWEDEN SUPERDISINTEGRANTS MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
• TABLE 260. SWITZERLAND SUPERDISINTEGRANTS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 261. SWITZERLAND SUPERDISINTEGRANTS MARKET SIZE, BY NATURAL SUPERDISINTEGRANTS, 2018-2030 (USD MILLION)
• TABLE 262. SWITZERLAND SUPERDISINTEGRANTS MARKET SIZE, BY SYNTHETIC SUPERDISINTEGRANTS, 2018-2030 (USD MILLION)
• TABLE 263. SWITZERLAND SUPERDISINTEGRANTS MARKET SIZE, BY MODIFIED CELLULOSE, 2018-2030 (USD MILLION)
• TABLE 264. SWITZERLAND SUPERDISINTEGRANTS MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
• TABLE 265. SWITZERLAND SUPERDISINTEGRANTS MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
• TABLE 266. TURKEY SUPERDISINTEGRANTS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 267. TURKEY SUPERDISINTEGRANTS MARKET SIZE, BY NATURAL SUPERDISINTEGRANTS, 2018-2030 (USD MILLION)
• TABLE 268. TURKEY SUPERDISINTEGRANTS MARKET SIZE, BY SYNTHETIC SUPERDISINTEGRANTS, 2018-2030 (USD MILLION)
• TABLE 269. TURKEY SUPERDISINTEGRANTS MARKET SIZE, BY MODIFIED CELLULOSE, 2018-2030 (USD MILLION)
• TABLE 270. TURKEY SUPERDISINTEGRANTS MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
• TABLE 271. TURKEY SUPERDISINTEGRANTS MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
• TABLE 272. UNITED ARAB EMIRATES SUPERDISINTEGRANTS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 273. UNITED ARAB EMIRATES SUPERDISINTEGRANTS MARKET SIZE, BY NATURAL SUPERDISINTEGRANTS, 2018-2030 (USD MILLION)
• TABLE 274. UNITED ARAB EMIRATES SUPERDISINTEGRANTS MARKET SIZE, BY SYNTHETIC SUPERDISINTEGRANTS, 2018-2030 (USD MILLION)
• TABLE 275. UNITED ARAB EMIRATES SUPERDISINTEGRANTS MARKET SIZE, BY MODIFIED CELLULOSE, 2018-2030 (USD MILLION)
• TABLE 276. UNITED ARAB EMIRATES SUPERDISINTEGRANTS MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
• TABLE 277. UNITED ARAB EMIRATES SUPERDISINTEGRANTS MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
• TABLE 278. UNITED KINGDOM SUPERDISINTEGRANTS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 279. UNITED KINGDOM SUPERDISINTEGRANTS MARKET SIZE, BY NATURAL SUPERDISINTEGRANTS, 2018-2030 (USD MILLION)
• TABLE 280. UNITED KINGDOM SUPERDISINTEGRANTS MARKET SIZE, BY SYNTHETIC SUPERDISINTEGRANTS, 2018-2030 (USD MILLION)
• TABLE 281. UNITED KINGDOM SUPERDISINTEGRANTS MARKET SIZE, BY MODIFIED CELLULOSE, 2018-2030 (USD MILLION)
• TABLE 282. UNITED KINGDOM SUPERDISINTEGRANTS MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
• TABLE 283. UNITED KINGDOM SUPERDISINTEGRANTS MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
• TABLE 284. SUPERDISINTEGRANTS MARKET SHARE, BY KEY PLAYER, 2023
• TABLE 285. SUPERDISINTEGRANTS MARKET, FPNV POSITIONING MATRIX, 2023

The Superdisintegrants Market was valued at USD 567.93 million in 2023, expected to reach USD 629.44 million in 2024, and is projected to grow at a CAGR of 10.92%, to USD 1,173.48 million by 2030.

Superdisintegrants are critical components in the pharmaceutical industry, primarily used in the formulation of tablets and capsules to facilitate their rapid disintegration upon contact with biological fluids, hence ensuring quick drug release and absorption. Their necessity arises from the growing demand for efficient drug delivery systems, and their applications span across various types of oral solid dosage forms. The end-use scope primarily includes pharmaceutical manufacturers who require effective disintegration solutions for immediate-release tablets and capsules. The market is driven by factors such as an increasing aging population needing rapid-acting therapeutics, advances in pharmaceutical technologies, and the shift towards generic drugs which rely heavily on efficient production processes. Furthermore, innovations in drug formulation continue to propel the need for better superdisintegrants, presenting opportunities for companies to develop novel compounds offering improved performance, biocompatibility, and cost-effectiveness. Emerging markets with expanding healthcare infrastructure provide considerable potential for growth. However, limitations exist due to stringent regulatory requirements and high costs of innovation and quality control, which can hinder quick market access and thus growth. Research and development into new sources of superdisintegrants, such as biopolymers, could provide breakthroughs, minimizing production costs and addressing safety concerns. Moreover, a focus on personalized medicine and patient-centric drug delivery systems could spur innovations in superdisintegrants that align with specific patient needs, such as tailored drug release profiles. The market's competitive landscape is characterized by constant innovation and product differentiation, thereby necessitating a strong emphasis on R&D and strategic collaborations. Companies are recommended to invest in advanced manufacturing technologies and sustainable practices to stay ahead. Lastly, navigating the regulatory landscape efficiently can also create opportunities by accelerating time-to-market for new superdisintegrant formulations, thus enhancing their market position.

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Superdisintegrants Market

The Superdisintegrants Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

• Market Drivers
  • Increasing consumption of orally disintegrating tablets and capsules
  • Rising adoption of the generic drugs
• Market Restraints
  • Concerns related to the safety and quality of product
• Market Opportunities
  • Development of new superdisintegrants for the pharmaceutical industry
  • Acceptance of natural superdisintegrants
• Market Challenges
  • High-cost associated with manufacturing of superdisintegrants

Porter's Five Forces: A Strategic Tool for Navigating the Superdisintegrants Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Superdisintegrants Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Superdisintegrants Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Superdisintegrants Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Superdisintegrants Market

A detailed market share analysis in the Superdisintegrants Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Superdisintegrants Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Superdisintegrants Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Superdisintegrants Market

A strategic analysis of the Superdisintegrants Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Superdisintegrants Market, highlighting leading vendors and their innovative profiles. These include Anshul Life Sciences, Asahi Kasei Corporation, Ashland Global Specialty Chemicals Inc., Avantor Performance Materials, LLC, BASF SE, DFE Pharma GmbH & Co KG, DowDuPont Inc., FMC Corporation, Gangwal Chemicals Pvt. Ltd., Huber Corporation, JRS PHARMA GmbH + Co. KG, Nippon Soda Co., Ltd., NITIKA PHARMACEUTICAL SPECIALITIES PVT. LTD., Roquette Freres S.A., and Sigachi Industries Pvt Ltd..

Market Segmentation & Coverage

This research report categorizes the Superdisintegrants Market to forecast the revenues and analyze trends in each of the following sub-markets:

• Based on Type, market is studied across Natural Superdisintegrants and Synthetic Superdisintegrants. The Natural Superdisintegrants is further studied across Gums, Mucilage, and Plantago Ovata Mucilage. The Synthetic Superdisintegrants is further studied across Calcium Silicates, Crospovidone, Ion Exchange Resins, Modified Cellulose, and Modified Starch. The Modified Cellulose is further studied across Croscarmellose Sodium and Low-Substituted Hydroxypropyl Cellulose.
• Based on Formulation, market is studied across Mouth-Dissolving Films and Tablets & Capsules.
• Based on Therapeutic Area, market is studied across Cardiovascular Diseases, Gastrointestinal Diseases, Hematological Diseases, Infectious Diseases, Inflammatory Diseases, Neurological Diseases, and Oncology.
• Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

• 1.1. Objectives of the Study
• 1.2. Market Segmentation & Coverage
• 1.3. Years Considered for the Study
• 1.4. Currency & Pricing
• 1.5. Language
• 1.6. Stakeholders

2. Research Methodology

• 2.1. Define: Research Objective
• 2.2. Determine: Research Design
• 2.3. Prepare: Research Instrument
• 2.4. Collect: Data Source
• 2.5. Analyze: Data Interpretation
• 2.6. Formulate: Data Verification
• 2.7. Publish: Research Report
• 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

• 5.1. Market Dynamics
  • 5.1.1. Drivers
    • 5.1.1.1. Increasing consumption of orally disintegrating tablets and capsules
    • 5.1.1.2. Rising adoption of the generic drugs
  • 5.1.2. Restraints
    • 5.1.2.1. Concerns related to the safety and quality of product
  • 5.1.3. Opportunities
    • 5.1.3.1. Development of new superdisintegrants for the pharmaceutical industry
    • 5.1.3.2. Acceptance of natural superdisintegrants
  • 5.1.4. Challenges
    • 5.1.4.1. High-cost associated with manufacturing of superdisintegrants
• 5.2. Market Segmentation Analysis
• 5.3. Porter's Five Forces Analysis
  • 5.3.1. Threat of New Entrants
  • 5.3.2. Threat of Substitutes
  • 5.3.3. Bargaining Power of Customers
  • 5.3.4. Bargaining Power of Suppliers
  • 5.3.5. Industry Rivalry
• 5.4. PESTLE Analysis
  • 5.4.1. Political
  • 5.4.2. Economic
  • 5.4.3. Social
  • 5.4.4. Technological
  • 5.4.5. Legal
  • 5.4.6. Environmental

6. Superdisintegrants Market, by Type

• 6.1. Introduction
• 6.2. Natural Superdisintegrants
  • 6.2.1. Gums
  • 6.2.2. Mucilage
  • 6.2.3. Plantago Ovata Mucilage
• 6.3. Synthetic Superdisintegrants
  • 6.3.1. Calcium Silicates
  • 6.3.2. Crospovidone
  • 6.3.3. Ion Exchange Resins
  • 6.3.4. Modified Cellulose
    • 6.3.4.1. Croscarmellose Sodium
    • 6.3.4.2. Low-Substituted Hydroxypropyl Cellulose
  • 6.3.5. Modified Starch

7. Superdisintegrants Market, by Formulation

• 7.1. Introduction
• 7.2. Mouth-Dissolving Films
• 7.3. Tablets & Capsules

8. Superdisintegrants Market, by Therapeutic Area

• 8.1. Introduction
• 8.2. Cardiovascular Diseases
• 8.3. Gastrointestinal Diseases
• 8.4. Hematological Diseases
• 8.5. Infectious Diseases
• 8.6. Inflammatory Diseases
• 8.7. Neurological Diseases
• 8.8. Oncology

9. Americas Superdisintegrants Market

• 9.1. Introduction
• 9.2. Argentina
• 9.3. Brazil
• 9.4. Canada
• 9.5. Mexico
• 9.6. United States

10. Asia-Pacific Superdisintegrants Market

• 10.1. Introduction
• 10.2. Australia
• 10.3. China
• 10.4. India
• 10.5. Indonesia
• 10.6. Japan
• 10.7. Malaysia
• 10.8. Philippines
• 10.9. Singapore
• 10.10. South Korea
• 10.11. Taiwan
• 10.12. Thailand
• 10.13. Vietnam

11. Europe, Middle East & Africa Superdisintegrants Market

• 11.1. Introduction
• 11.2. Denmark
• 11.3. Egypt
• 11.4. Finland
• 11.5. France
• 11.6. Germany
• 11.7. Israel
• 11.8. Italy
• 11.9. Netherlands
• 11.10. Nigeria
• 11.11. Norway
• 11.12. Poland
• 11.13. Qatar
• 11.14. Russia
• 11.15. Saudi Arabia
• 11.16. South Africa
• 11.17. Spain
• 11.18. Sweden
• 11.19. Switzerland
• 11.20. Turkey
• 11.21. United Arab Emirates
• 11.22. United Kingdom

12. Competitive Landscape

• 12.1. Market Share Analysis, 2023
• 12.2. FPNV Positioning Matrix, 2023
• 12.3. Competitive Scenario Analysis
• 12.4. Strategy Analysis & Recommendation

Companies Mentioned

• 1. Anshul Life Sciences
• 2. Asahi Kasei Corporation
• 3. Ashland Global Specialty Chemicals Inc.
• 4. Avantor Performance Materials, LLC
• 5. BASF SE
• 6. DFE Pharma GmbH & Co KG
• 7. DowDuPont Inc.
• 8. FMC Corporation
• 9. Gangwal Chemicals Pvt. Ltd.
• 10. Huber Corporation
• 11. JRS PHARMA GmbH + Co. KG
• 12. Nippon Soda Co., Ltd.
• 13. NITIKA PHARMACEUTICAL SPECIALITIES PVT. LTD.
• 14. Roquette Freres S.A.
• 15. Sigachi Industries Pvt Ltd.